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Hydrogels are three‐dimensional, crosslinked networks of hydrophilic polymers
swollen with a large amount of water or biological fluids, without dissolving. Dextrin,
a low‐molecular‐weight carbohydrate composed by glucose residues, has been used
to develop an injectable hydrogel for biomedical applications. Dextrin was first
oxidized to introduce aldehyde groups, which then reticulate with adipic acid
dihydrazide, forming the dextrin‐based hydrogel (HG). The HG and its components
were tested for cyto‐ and genotoxicity according to the International Standard ISO
10993‐3 on the biological evaluation of medical devices. To assess genotoxicity, a
battery of in vitro genotoxicity tests employing both eukaryotic and prokaryotic
models was performed: comet assay, cytokinesis‐block micronucleus assay and Ames
test. Our data revealed that the HG (IC50 = 2.8 mg/mL) and oxidized dextrin by itself
(IC50 = 1.2 mg/mL) caused a concentration‐dependent decrease in cellular viability of
human lymphoblastoid TK6 cells after 24 hours of exposure to the test agents.
However, these concentrations are unlikely to be reached in vivo. In addition, no
significant increase in the DNA and chromosomal damage of TK6 cells exposed to
non‐cytotoxic concentrations of the HG and its isolated components was detected.
Furthermore, neither the HG nor its metabolites exerted a mutagenic effect in different
of Salmonella typhimurium strains and in an Escherichia colimix. Our data demonstrated
the genocompatibility of the HG (up to 3.5 mg/mL) for biomedical applications. To
our best acknowledge, this is the first report with a detailed genotoxicity assessment
of an aldehyde‐modified polysaccharide/adipic acid dihydrazide hydrogel.
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Hydrogels are three‐dimensional, crosslinked networks of hydrophilic
polymers swollen with a large amount of water or biological
fluids. They generally are biocompatible, biodegradable and mimic
many of the properties of the native extracellular matrix, namely
high‐water content and viscoelastic mechanical properties, functional
activity as provisional artificial support for cells and lack of mechanical
strength. They display porosity and interconnectivity, enabling thewileyonlinelibrary.com/jtransport of nutrients, gas diffusion and removal of metabolic
wastes, and they can act as carriers of growth factors or cells and
as drug delivery systems. Moreover, hydrogels can be injectable,
enabling less invasive clinical procedures, and can conform to the
shape of the surface to which they are applied. Therefore, hydrogels
are used in clinical practice and experimental medicine in diverse
applications, including tissue engineering and as drug delivery
systems (Drury & Mooney, 2003; Geckil, Xu, Zhang, Moon, &
Demirci, 2010; Hoare & Kohane, 2008).© 2018 John Wiley & Sons, Ltd.ournal/jat 639
640 PEREIRA ET AL.Dextrins are low‐molecular‐weight carbohydrates produced by
partial hydrolysis of glycogen or starch obtained under acidic and/or
enzymatic conditions (Gonçalves, Moreira, Carvalho, Silva, & Gama,
2016). They are composed by a linear (α1 → 4)‐D‐glucose residues
backbone, branched with (α1 → 4,6)‐linked‐D‐glucose residues. Some
dextrins also present (α1 → 6)‐D‐glucose residues in a small percent-
age (Silva et al., 2014; Tomasik, Wiejak, & Pałasiński, 1989).
Dextrin is a low cost, broadly available raw material, generally
regarded as safe and widely used in many industrial applications, such
as adhesives, textiles, cosmetics and foods (Gonçalves et al., 2016;
Tomasik et al., 1989). Regarding biomedical applications, dextrin is still
relatively unexplored, being clinically used as a peritoneal dialysis solu-
tion that can also perform as a drug delivery solution (Peers & Gokal,
1998; Takatori et al., 2011; Treetharnmathurot et al., 2009), and as a
wound dressing agent (DeBusk & Alleman, 2006). Although there are
limited numbers of current biomedical applications, dextrin displays a
set of advantages that potentiates its use specifically in the biomate-
rials field. It is a biocompatible and non‐immunogenic material, degrad-
able in vivo by α‐amylases and its molecular weight ensures renal
elimination avoiding tissue accumulation upon repeated administra-
tion (Hreczuk‐Hirst, Chicco, German, & Duncan, 2001; Moreira et al.,
2010). During the last decade, due to its properties, which include
the solubility in both water and dimethyl sulfoxide (DMSO), availability
in medical grade, and availability of hydroxyl groups, dextrin has been
explored for the design and fabrication of hydrogels suitable for con-
trolled release applications and as tissue engineering scaffolds (Das
& Pal, 2015; Gonçalves et al., 2016).
Dextrin has been used by our research group to develop a novel
fully resorbable and injectable hydrogel. Dextrin was first oxidized
(ODEX) with sodium periodate to produce dialdehydes, which in turn
then reticulate with adipic acid dihydrazide (ADH), forming the
dextrin‐based hydrogel (HG) (Figure 1) (Molinos, Carvalho, Silva, & Gama,
2012). The cross‐linked ODEX is an in situ gelling hydrogel, which
displays a three‐dimensional network with interconnective pores, and is
able to incorporate nanogels, cells and biomolecules for biomedical
applications (Molinos et al., 2012; Silva et al., 2014; Silva et al., 2016).
The development of biomaterials for medical applications includes
extensive preclinical testing to demonstrate their safety and efficacy
according to the regulatory agencies requirements. In this context,FIGURE 1 Chemical structures of oxidized dextrin, adipic acid dihydrazid
between oxidized dextrin and adipic acid dihydrazideour group has already shown the in vivo biocompatibility of the HG
after subcutaneous implantation in a rat model (Silva et al., 2016). In
the same study, the HG was associated with granular ceramics and
was able to stabilize the granules in the implant site, demonstrating
its potential for the development of injectable bone substitutes (Silva
et al., 2016).
The systemic biocompatibility testing of materials includes
genotoxicity assessment—evaluation of the presence of a DNA reac-
tive component that may result in mutagenicity and carcinogenicity.
The International Standard ISO 10993 on the biological evaluation of
medical devices stipulates that implant devices developed to be in
contact with tissue/bone and blood for longer than 24 hours must
undergo genotoxicity assessment (ISO 10993‐1, 2009). A battery of
in vitro genotoxicity tests employing prokaryotic and eukaryotic
models shall be used to determine the potential to induce gene muta-
tions, changes in chromosome structure and number, and other DNA
or gene abnormalities caused by the medical devices, materials
and/or their extracts (ISO 10993‐3, 2014). Thus, in the present work,
the genotoxic potential of the dextrin‐based hydrogel (HG) and its iso-
lated components (ODEX and ADH) was assessed by the Ames test,
micronucleus (MN) and comet assays.2 | MATERIALS AND METHODS
2.1 | Chemicals
All chemicals used were of the highest purity or analytical grade
available. Dextrin used in this work was Tackidex B 167 (batch E
1445), generously assigned by Roquette (Lestrem, France). Sodium
m‐periodate (CAS no. 7790‐28‐5), diethylene glycol (CAS no. 111‐
46‐6) and ADH (CAS no. 1071‐93‐8), 3‐(4,5‐dimethylthiazol‐2‐yl)‐
2,5‐diphenyltetrazolium bromide (MTT; CAS no. 298‐93‐1), methyl
methanesulfonate (MMS; CAS no. 66‐27‐3), DMSO (CAS no. 37‐68‐
5), Triton X‐100 (CAS no. 9002‐93‐1), low melting point agarose
(CAS no. 39346‐81‐1) and cytochalasin B (cytoB; CAS no. 14930‐
96‐2) were purchased from Sigma‐Aldrich (St. Louis, MO, USA).
Absolute ethanol (CAS no. 64‐17‐5), sodium hydroxide (NaOH; CAS
no. 1310‐73‐2), sodium chloride (NaCl; CAS no. 7647‐14‐5),e and of the corresponding hydrogel formed after reticulation reaction
TABLE 1 Concentrations of the HGdil, ODEX and ADH used in the
cyto‐ and genotoxicity testing
HGdil (mg/mL) ODEX (mg/mL) ADH (mg/mL)
NC 0.000 0.000 0.000
C1 0.124 0.118 0.006
C2 0.248 0.235 0.013
C3 0.491 0.466 0.034
C4 0.965 0.916 0.049
C5 1.865 1.770 0.095
C6 3.494 3.316 0.178
ADH, adipic acid dihydrazide; HGdil, diluted dextrin‐based hydrogel; ODEX,
oxidized dextrin.
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Tris base (CAS no. 77‐86‐1) and Giemsa's azur eosin methylene blue
(CAS no. 51811‐82‐6) were obtained from Merck (Darmstadt,
Germany). Mitomycin C (MMC; CAS no. 50‐07‐7) and Molecular
Probes® SYBR® Gold was purchased from Thermo Fisher Scientific
(Waltham, MA, USA), while ethylenediaminetetraacetic acid disodium
salt (Na2EDTA; CAS no. 6381‐92‐6) was obtained from Prolab
(Quebec, Canada). Phosphate‐buffered saline (PBS; CAS no. 10049‐
21‐5) and normal melting point agarose were supplied by Lonza (Basel,
Switzerland), while methanol (CAS no. 67‐56‐1) was purchased from
VWR (Radnor, PA, USA).
2.2 | Material preparation
2.2.1 | Dextrin oxidation
Dextrin oxidation was performed as described by Pereira et al. (2018).
Briefly, aqueous solutions of dextrin (2% w/v) were oxidized with
sodium m‐periodate, to yield the theoretical degree of oxidation of
40%, at room temperature, with stirring, and in the dark. After
20 hours, the oxidation reaction was stopped by dropwise addition
of an equimolar amount of diethylene glycol to reduce any unreacted
periodate. Sodium m‐periodate and diethylene glycol were removed
by ultrafiltration, using a membrane with a molecular weight cut‐off
1000 Da (Merck Millipore, Billerica, MA, USA), and then lyophilized.
2.2.2 | Preparation of the dextrin‐based hydrogel
ODEX was dissolved in PBS solution (30% w/v) and the solution was
sterilized by gamma irradiation (IONISOS, Dagneux, France), using a
60Co source, at 20 kGy (2 kGy/h), at room temperature. ADH was also
dissolved in PBS solution (3.76% w/v) and sterilized by filtration, using
a 0.22 μm pore filter membrane (Pall Corporation, Ann Arbor, MI,
USA). For the crosslinking reaction, ODEX and ADH solutions were
mixed in a 7:3 volume ratio, respectively.
2.3 | Cell culture
The human lymphoblastoid TK6 cell line (ATCC® CRL8015™) was
used for the cyto‐ and genotoxicity testing. The cells were maintained
in RPMI‐1640 medium (Thermo Fisher Scientific) with 2 mM glutamine
supplemented with 10% heat‐inactivated fetal bovine serum (Thermo
Fisher Scientific), 100 units/mL of penicillin, 100 μg/mL of streptomy-
cin and 0.25 μg/mL of amphotericin (Thermo Fisher Scientific). Cells
were maintained in a humidified atmosphere with 5% CO2 at 37°C.
2.4 | Cell exposure conditions
For cyto‐ and genotoxicity testing, the HG was tested by an indirect
method, as the HG is not pipettable, it was diluted (HGdil) in culture
medium and different concentrations were prepared and tested
(Table 1). The HG constituents (ODEX and ADH), which are two of
its degradation products, were also tested separately, using the same
concentrations used for the assessment of the HGdil tested (Table 1).
Thus, for the MTT reduction and cytokinesis‐block MN (CBMN)assays, six concentrations of the HGdil (C1‐C6) were tested in parallel
with its individual components (ODEX and ADH) (Table 1). For
the comet assay, three non‐cytotoxic concentrations were tested
(C1‐C3). In the Ames test, only six different concentrations of HGdil
were tested (C1‐C6). For all the experiments, a negative control
(NC) and an appropriate positive control (PC) were used.2.5 | Assessment of the cellular viability
The cytotoxicity of the HG, ODEX and ADH was evaluated based on
their effects on cell viability assessed by the MTT reduction assay
following 24 hours of exposure, as recommended in ISO 10993‐5
(2009). To carry out the experiment, 1.7 × 105 cells/mL were seeded
in 96‐well round bottom plates. After 24 hours, cells were incubated
with different concentrations of the HGdil, ODEX and ADH, culture
medium (NC) or with DMSO (PC). At the end of the exposure period
(24 hours), the test agents were removed by centrifugation (130 g,
2 minutes) and 100 μL of MTT solution (1 mg/mL in serum‐free
culture medium) were added to each well and incubated for 3 hours
at 37°C in the dark. For MTT removal, plates were centrifuged
(300 g, 10 minutes), and the produced formazan was solubilized with
200 μL DMSO. Thereafter, 150 μL of the supernatant were trans-
ferred to a 96‐well flat bottom plate and the absorbance was mea-
sured at 570 and 690 nm (reference wavelength), using a Cambrex
ELx808 microplate reader (BioTek, Winooski, VT, USA). Two indepen-
dent experiments were performed, each in triplicate.2.6 | Assessment of the DNA damage
The comet assay, also known as single‐cell gel electrophoresis assay,
was performed to evaluate the potential DNA damage induced by
the HG and its components. For that purpose, TK6 cells were seeded
on to 24‐well plates at a density of 1.7 × 105 cells/mL. After 24 hours,
cells were treated with non‐toxic concentrations of HGdil, ODEX and
ADH (C1‐C3), selected based on the cellular viability data. Cells incu-
bated with culture medium and the DNA alkylating agent MMS
(40 μg/mL; 1 hour) served as NC and PC, respectively. At the end of
the exposure period (24 hours), incubation media were removed and
cells washed with PBS pH 7.4. The comet assay was performed in
alkaline conditions (pH >13) as previously described by Mesquita
et al. (2017), with minor modifications. All the steps described were
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age. Briefly, aliquots of 1 × 105 cells in PBS were centrifuged at 400 g
for 3 minutes. The cell pellets were resuspended in 100 μL 1% low
melting point agarose and 5 μL of each cell suspension layered on to
dry microscope slides (VWR, Darmstadt, Germany) pre‐coated with
1% normal melting point agarose. After gel solidification at 4°C, slides
were placed in a Coplin jar and immersed in ice‐cold lysis solution
(2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris‐base, 10 M NaOH, pH
10, supplemented with 1% Triton‐X 100) for 1.5 hours at 4°C
(protected from light), to lyse the cells and separate DNA from
histones. For DNA unwinding, all slides were immersed in freshly pre-
pared electrophoresis buffer (200 mM Na2EDTA, 0.3 M NaOH pH >13)
in the electrophoresis unit for 40 minutes at 4°C, followed by electro-
phoresis for 20 minutes at 30 V and 300 mA. Then, the gels were
washed with H2O and fixed with ethanol 70% and 96% for 15 minutes
each, at room temperature. After air‐drying the slides overnight, DNA
was stained with a 0.07% SYBR® Gold solution. The slides were
coded, and one scorer performed the comet analysis using a
fluorescence microscope (Nikon Eclipse E400 microscope (Amsterdam,
Netherlands) attached to an epifluorescence illuminator Nikon C‐SHG1)
with a 400× magnification and the image analysis software Comet Assay
IV (Perceptive Instruments, Bury St Edmunds, Suffolk, UK). The percent-
age of DNA in the comet tail (percentage tail intensity) and the olive tailCBPI ¼ no:mononucleate cellsð Þ þ 2 × no:binucleate cellsð Þ þ 3 × no:multinucleate cellsð Þ
Total number of cellsð Þmoment (OTM) were used as a measure of the amount of DNA damage.
At least 100 cells were scored (50 for each replicate gel) and three
independent experiments were performed, each in triplicate.2.7 | Assessment of the chromosomal damage
The MN assay was performed to evaluate the potential chromosome
damage induced by the HG, ODEX and ADH in TK6 cells, according
to the OECD test guideline (TG) 487 (OECD, 2016), in the presence
of cytoB, an actin polymerization inhibitor. The OECD TG 487 pro-
posed an extended exposure treatment of 1.5‐2.0 normal cell cycles.
As a result, the doubling time of the TK6 cells was approximately
15 hours, the exposure period used in this work was 24 hours. To
carry out the experiment, 1.7 × 105 cells/mL were seeded in 12‐well
plates and then treated for 24 hours with different concentrations of
HGdil, ODEX and ADH, with 0.04 μg/mL MMC (PC) and culture
medium (NC). At the end of the exposure period, cells were centri-
fuged (100 g, 7 minutes), resuspended in fresh culture medium and
transferred on to a new 12‐well plate. The culture medium was then
supplemented with cytoB at a final concentration of 4 μg/mL. After
30 hours (recovery time), cells were transferred into 15 mL conical
tubes, centrifuged (100 g, 7 minutes) and the supernatant discarded
by inverting the tube. The residual supernatant was resuspended by
gentle agitation of tubes. Then, cells were incubated in 5 mL of a
hypotonic 0.075 M KCl solution for 4 minutes followed by the additionof 400 μL of an ice‐cold methanol/acetic acid pre‐fixing solution
(3:5 v/v) under gentle agitation. Samples were centrifuged again, and
resuspended in 5 mL of ice‐cold fixing solution (methanol/acetic acid,
5:1 v/v) and then centrifuged (100 g, 10 minutes). The supernatant
was decanted, the cell pellets were resuspended in the residual super-
natant and dropped on to clean glass slides and air‐dried. The slides
were stained with 3% Giemsa and analyzed using a light microscope
(Nikon E400 Eclipse) under a high magnification (400‐1000×). For this
test, two independent experiments were performed, each in duplicate.
For scoring, MN frequencies were analyzed in at least 2000 binucleate
cells per concentration and in the NC, equally divided among the rep-
licates. The criteria for MN and binucleate cells scoring were in accor-
dance with the principles described by Fenech (Fenech, 2007). Only
the concentrations whose cytotoxicity was below 55% ± 5% were
scored for MN. The cytotoxicity was measured in accordance with
the OECD TG 487 (OECD, 2016), by using the cytokinesis‐block pro-
liferation index (CBPI), which indicates the average number of cell
cycles per cell during the period of exposure to cytoB, and may be
used to calculate cell proliferation, as follows:
%Cytostasis ¼ 100 − 100 CBPIT − 1ð Þ÷; CBPIC − 1ð Þ½ ; T ¼ Test and
C ¼ Control
Where:For its determination at least 500 cells per slide were counted.2.8 | Assessment of mutagenicity
The mutagenic potential of the HG was assessed by the Ames
test, using the Ames MPF™ Penta I kit (Xenometrix AG, Allschwil,
Switzerland) according to the manufacturer's instructions and meeting
the requirements of the OECD TG 471 (OECD, 1997). Histidine‐
dependent auxotrophic mutants of Salmonella typhimurium (strains
TA98, TA100, TA1535 and TA1537) and tryptophan‐dependent auxo-
trophic mutants of Escherichia coli (strains WP2 uvrA and WP2
[pKM101]) were exposed to the HGdil in the absence and presence
of metabolic activation (Aroclor 1254‐induced rat liver S9 fraction).
Briefly, the mutant strains were grown overnight (the two E. coli
strains were grown separately overnight and then mixed—E. coli
Combo mix) and were exposed to different concentrations of the
HGdil, as well as to a positive and a negative control (PBS), all in tripli-
cate, for 90 minutes (E. coli Combo mix + S9 mix: 20 minutes), at 37°C,
under agitation in liquid minimal histidine (Salmonella strains) or tryp-
tophan (E. coli Combo mix) exposure media. After exposure, the cul-
tures were diluted in pH indicator medium lacking histidine or
tryptophan, transferred on to 384‐well plates and incubated at 37°C
for 48 hours. The bromocresol purple in the indicator medium turns
yellow as the pH drops because of the catabolic activity of revertant
bacteria that grow in the absence of the required amino acid. The
FIGURE 2 Effect of the different concentrations of the HGdil and its
isolated components—ODEX and ADH—on TK6 cell viability as
assessed by the MTT reduction assay. Cells were exposed to different
concentrations (C1‐C6) of the test agents for 24 h. Results were
calculated as percentage of the negative control and data are
presented as mean ± SD (n = 3 replicates per group) of two
independent experiments. Data were analyzed by one‐way ANOVA
followed by Dunnett's post hoc test: *P < 0.05, **P < 0.01 and
***P < 0.001 vs. HGdil. ADH, adipic acid dihydrazide; HGdil, diluted
hydrogel; ODEX, oxidized dextrin
PEREIRA ET AL. 643number of positive (yellow) wells of 48 wells per replicate and concen-
tration were counted and compared with the number of spontaneous
revertants obtained in the NC. Specific PCs were used to validate the
assay. The PCs used in the absence of metabolic activation (S9 mix)
were as follows: 2 μg/mL 2‐nitrofluorene for the TA98 strain; 0.1
and 2 μg/mL 4‐nitroquinoline‐N‐oxide for the TA100 strain and E. coli
Combo mix, respectively; 100 μg/mL N4‐aminocytidine for the
TA1535 strain; and 15 μg/mL 9‐aminoacridine for the TA1537 strain.
The PCs used in the presence of the S9 mix were 1 and 50 μg/mL
2‐aminoanthracene for theTA98 strain and E. coli Combo mix, respec-
tively, and 2.5 μg/mL 2‐aminoanthracene for the TA100, TA1535 and
TA1537 strains. Evaluation and interpretation of the results were
performed according to the manufacturers’ recommended criteria.
The baseline value corresponds to the mean ± SD of the NC. If the
obtained value was less than 1.0, it was set to 1. The fold increase
over the baseline, which is the ratio of the mean number of positive
wells divided by the baseline, was determined for each concentration.
A test compound showing a clear concentration‐response and/or
yields a multiple fold increase greater than 2.0, is classified as a
mutagen.TABLE 2 Comet assay analysis of DNA damage inTK6 cells exposed
for 24 h to different concentrations of the HGdil and its isolated
components, ODEX and ADH
Tail intensity (%) Olive tail moment2.9 | Statistical analysis
Experimental data are presented as mean ± SD. Data were analyzed
using the Prism® version 6.1 software (GraphPad Software Inc., La
Jolla, CA, USA). Statistical analyses of the cytotoxicity and comet
assay data were performed by ANOVA followed by the multiple
comparison Dunnett post‐hoc test. The cytotoxicity concentration‐
response curves were obtained using the method of least squares
and the comparison between the curves and log half‐maximal
inhibitory concentration (IC50) values were performed using extra
sum‐of‐squares F ‐test. For the MN assay data, a chi‐squared test
was performed to test differences of the MN frequency between
exposed and control cells. Significance was accepted at P < 0.05.NC 7.02 ± 1.38 0.92 ± 0.26
HGdil
C1 7.13 ± 0.87 0.93 ± 0.32
C2 7.60 ± 1.47 0.98 ± 0.41
C3 7.84 ± 1.57 1.08 ± 0.36
ODEX
C1 7.15 ± 1.54 0.99 ± 0.40
C2 7.60 ± 1.49 1.11 ± 0.41
C3 8.58 ± 1.41 1.30 ± 0.39
ADH
C1 6.93 ± 1.06 0.88 ± 0.32
C2 7.17 ± 1.51 0.89 ± 0.27
C3 6.37 ± 1.48 0.82 ± 0.33
MMS 73.98 ± 8.67* 22.92 ± 6.99*
ADH, adipic acid dihydrazide; HGdil, diluted dextrin‐based hydrogel; MMS,
methyl methanesulfonate; NC, negative control; ODEX, oxidized dextrin.
MMS (40 μg/mL, 1 h) was used as positive control. Results are presented
as mean ± SD (n = 3 replicates per group) of three independent experi-
ments. Data were analyzed by one‐way ANOVA followed by Dunnett's
post hoc test:
*P < 0.001 vs. NC.3 | RESULTS
3.1 | Effects on cellular viability
The cytotoxicity of the HG was evaluated based on the impact of the
HGdil and its constituents on cellular viability as assessed by the MTT
reduction assay in TK6 cells following 24 hours of exposure to the
compounds. As shown in Figure 2, exposure to the HGdil markedly
decreased cell viability in a concentration‐dependent manner down
to 41.49% ± 2.80% of control. Regarding the effects of the isolated
components of the HG upon cell viability, it was observed that ADH
did not induce any significant cytotoxicity at the tested concentra-
tions, while ODEX significantly decreased the viability of the cells, also
in a concentration‐dependent manner, suggesting that the cytotoxicity
of HGdil is due to the ODEX. Analysis of the concentration‐responses
curves for the HGdil and ODEX (Supporting information Figure S1)
revealed half‐maximal inhibitory concentration (IC50) values of 2.810
(CI: 2.451‐3.316) and 1.147 (CI: 1.022‐1.291) mg/mL, respectively.3.2 | Effects on DNA level
Based on the above cytotoxicity data, three non‐cytotoxic concentra-
tions of the HGdil and of its isolated components (ODEX and ADH)
were selected (C1‐C3) to investigate their potential DNA damaging
effect, by the comet assay, in human lymphoblastoid TK6 cells after
24 hours of exposure. The obtained results are represented in
Table 2. The TK6 cell line showed low levels of baseline DNA damage
644 PEREIRA ET AL.as demonstrated by its percentage tail intensity (7.02 ± 1.38) and OTM
(0.92 ± 0.26) values. As depicted in Figure 3, cells exposed to different
concentrations of the HGdil, ODEX and ADH displayed a predominant
round‐shaped nucleus similar to the control cells (NC) indicating that
the HG and its components did not cause significant DNA damage in
human lymphoblastoid cells. As expected cells exposed to MMS (PC)
exhibited a pronounced comet tail indicative of DNA damage accompa-
nied by a significant increase in both percentage tail intensity
(73.98 ± 8.67) and OTM (22.92 ± 6.99) compared with control cells.3.3 | Effects on chromosomal level
The MN scoring was only performed in concentrations of HGdil, ODEX
and ADH inducing cytotoxicity levels below 55% ± 5%, as cell death
can confound the interpretation of the CBMN assay data. The results
relative to MN frequency (percentage MN) in binucleate cells exposed
to HG, ODEX and ADH and its respective cytotoxicity are presented
in Figure 4. In agreement with the MTT assay data, the HGdil and
ODEX induced a concentration‐dependent increase in cytotoxicity,
greater in ODEX‐exposed cells, while ADH did not cause cytotoxicity.
TK6 cells treated with the highest HG concentration (3.494 mg/mL)
exhibited high levels of cytotoxicity (89.99% ± 2.26% of control),
and accordingly were not scored for MN frequency. Regarding ODEX,
cells incubated with the concentration C5 (1.770 mg/mL) displayed a
cytotoxicity of 89.28% ± 1.27% of control, so that, only four concen-
trations of ODEX were scored for MN. As ADH was not cytotoxic, all
the concentrations tested were used for MN scoring. After 24 hours
of TK6 cell incubation with the tested concentrations of HGdil, ODEX
and ADH no significant MN induction was observed, while MMCFIGURE 3 . Representative images (400× magnification) of the comet ass
concentration (C3) of the HGdil (0.491 mg/mL), ODEX (0.466 mg/mL) and
control. ADH, adipic acid dihydrazide; HGdil, diluted hydrogel; MMS, meth
[Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 4 Cytokinesis‐block MN assay in TK6 cells exposed to different
ADH—for 24 h. MMC (0.04 μg/mL) was used as the positive control. Colu
presented as mean ± SD (n = 2 replicates per group) of two independent ex
ADH, adipic acid dihydrazide; HGdil, diluted hydrogel; MMC, mitomycin C;
oxidized dextrin(with a cytotoxicity of 37.46% ± 1.37%) significantly increased the
number of binucleate cells with MN (P < 0.001) compared to control
cells. These results indicate that HG does not induce chromosome
damage on TK6 cells under our experimental conditions.
3.4 | Mutagenic effects
Data obtained in the Ames test for mutagenicity, in the presence and
in the absence of human S9 fraction are presented in Tables 3 and 4,
respectively. The results showed that HGdil did not induce a twofold
increase in the number of positive wells in any of the strains used
compared to the NC at any of the concentrations tested, in either
the presence or absence of S9 metabolic activation. In addition, a clear
dose‐dependent increase was not observed in the number of positive
wells. On the other hand, all the mutagenic PCs tested produced
more than a threefold increase in the number of revertant colonies
compared to the NC. Taken together, the above‐described results
indicated that HG is not mutagenic, at least up to 3.5 mg/mL.4 | DISCUSSION
In the present work, a combination of different genotoxicity assays
was used to assess the genotoxic potential of the HG and its isolated
components (ODEX and ADH), which were tested in a mammalian cell
line but also in prokaryotic models.
The mammalian cell line used was TK6 human lymphoblastoid
cells. These cells have a wild‐type p53 gene, are karyotypically stable,
display DNA repair capacity and stable spontaneous mutation fre-
quencies (Islaih et al., 2005; Lorge et al., 2016; Pfuhler et al., 2011;
Zhang et al., 1995). According to the 5th International Workshop onay in TK6 cells after 24 h of exposure to NC and to the highest tested
ADH (0.034 mg/mL) used. MMS (40 μg/mL, 1 h) was used as positive
yl methanesulfonate; NC, negative control; ODEX, oxidized dextrin
concentrations of the HGdil and its isolated components—ODEX and
mns: % MN in binucleate cells; lines: % cytotoxicity. Results are
periments. Data were analyzed by chi‐squared test: *P < 0.001 vs. NC.
% MN, percentage of micronucleus; NC, negative control; ODEX,
TABLE 3 Mutagenic potential of the different concentrations of the diluted hydrogel assessed by the Ames test using different strains of S.
typhimurium (TA98, TA100, TA1535 and TA1537) and a combination of two E. coli strains (E. coli Combo mix), in the absence of metabolic acti-
vation (S9 mix)





















NC 7.00 ± 4.36 10.33 ± 2.89 1.33 ± 0.58 9.00 ± 1.73 8.67 ± 2.52
C1 12.33 ± 3.21 1.09 9.33 ± 2.08 0.71 1.67 ± 1.15 0.87 8.00 ± 3.61 0.75 4.33 ± 0.58 0.39
C2 10.33 ± 1.53 0.91 12.76 ± 3.51 0.96 3.00 ± 1.00 1.57 9.67 ± 2.31 0.90 6.67 ± 2.31 0.60
C3 10.33 ± 0.58 0.91 13.00 ± 4.00 0.98 0.67 ± 0.58 0.35 11.67 ± 3.06 1.09 4.00 ± 2.65 0.36
C4 12.00 ± 4.00 1.06 12.00 ± 2.00 0.91 1.67 ± 1.15 0.87 6.00 ± 1.00 0.56 2.67 ± 1.53 0.24
C5 11.00 ± 2.00 0.97 15.33 ± 4.16 1.16 3.00 ± 0.00 1.57 7.00 ± 2.65 0.65 5.00 ± 1.00 0.45
C6 11.00 ± 2.65 0.97 16.67 ± 4.62 1.26 1.67 ± 2.08 0.87 5.67 ± 1.15 0.53 3.33 ± 2.08 0.30
PC 48.00 ± 0.00 4.23* 46.67 ± 0.58 3.53* 48.00 ± 0.00 25.12* 48.00 ± 0.00 4.47* 41.67 ± 2.08 3.73
NC, negative controls; PC, positive controls.
Results are presented as mean ± SD. The test compound with a clear concentration‐response and/or yields multiple fold increase greater than 2.0, was
classified as a mutagen and was designated with *.
PC were as follows: 2 μg/mL 2‐nitrofluorene for the TA98; 0.1 and 2 μg/mL 4‐nitroquinoline‐N‐oxide for the TA100 and E. coli Combo mix, respectively;
100 μg/mL N4‐aminocytidine for the TA1535; and 15 μg/mL 9‐aminoacridine for the TA1537.
TABLE 4 Mutagenic potential of the different concentrations of the diluted hydrogel assessed by the Ames test using different strains of Sal-
monella typhimurium (TA 98, TA 100, TA 1535 and TA 1537) and a combination of two Escherichia coli strains (E. coli Combo mix), in the presence
of metabolic activation (S9 mix)





















NC 3.67 ± 2.08 6.33 ± 2.52 1.33 ± 0.58 3.33 ± 1.53 4.00 ± 1.73
C1 1.33 ± 1.53 0.23 7.00 ± 2.00 0.79 0.67 ± 1.15 0.35 3.00 ± 1.73 0.62 6.00 ± 1.73 1.05
C2 2.00 ± 1.00 0.35 7.33 ± 1.53 0.83 0.33 ± 0.58 0.17 1.67 ± 0.58 0.34 2.33 ± 1.53 0.41
C3 1.67 ± 0.58 0.29 8.67 ± 2.52 0.98 0.67 ± 0.58 0.35 4.00 ± 2.00 0.82 3.67 ± 2.89 0.64
C4 3.00 ± 1.00 0.52 5.33 ± 0.58 0.60 1.00 ± 1.73 0.52 2.00 ± 0.00 0.41 2.67 ± 2.08 0.47
C5 2.33 ± 2.52 0.41 5.67 ± 1.53 0.64 0.67 ± 0.58 0.35 2.33 ± 2.08 0.48 4.67 ± 1.15 0.81
C6 2.00 ± 1.00 0.35 10.00 ± 0.00 1.13 1.67 ± 1.15 0.87 3.00 ± 1.73 0.62 3.33 ± 1.53 0.58
PC 48 ± 0.00 8.35* 47.67 ± 0.58 5.39* 27.67 ± 7.57 14.48* 48.00 ± 0.00 9.87* 32.00 ± 2.00 5.58*
NC, negative controls; PC, positive controls.
Results are presented as mean ± SD. According to the manufacturer's criteria, a test compound with a clear concentration‐response and/or yields multiple
fold increase greater than 2.0, was classified as a mutagen and was designated with *.
Positive controls (PCs) were as follows: 1 and 50 μg/mL 2‐aminoanthracene for the TA98 strain and E. coli Combo mix, respectively, and 2.5 μg/mL 2‐
aminoanthracene for the TA100, TA1535 and TA1537 strains.
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to p53‐compromised cells for evaluation of the MN induction
for human risk assessment (Pfuhler et al., 2011), because of “false”
positive results obtained in the p53‐compromised rodent cell lines
(e.g., V79, CHL and CHO cells) (Fowler et al., 2012). In this way, due
to inherent characteristics, TK6 cell line is already recommended in
the OECD TG 487 on in vitro mammalian cell MN test (OECD,
2016), being one of the most used cell models for such assay (Lorge
et al., 2016). Another advantage of using TK6 cells is that it is a well‐
studied human cell line, ease of culturing and its use eliminates the
donor to donor variability observed with primary human lymphocytes
(Sobol et al., 2012). Consequently, TK6 cell line may be deemed appro-
priate for performing in vitro genotoxicity assessment of medicaldevices for tissue regeneration purposes to be applied in tissues highly
vascularized, such as bone.
To avoid misleading positive results in the comet and CBMN
assays, the different concentrations of HGdil, ODEX and ADH were
first evaluated for their cytotoxicity. The results from the MTT reduc-
tion and CBMN (using CBPI method) showed that HGdil reduced
the viability in TK6 cells, in a concentration‐dependent manner.
Analysis of the isolated components of HG revealed that while ADH
was non‐cytotoxic, ODEX induced cytotoxicity in a concentration‐
dependent manner. It is important to note that ADH is a minor com-
ponent of the HG (~5% w/w), thus lower concentrations were tested.
Silva et al. evaluated and compared the cytotoxicity of ADH and glu-
taraldehyde (Silva et al., 2014). The latter is a widely used crosslinker,
646 PEREIRA ET AL.often reported to be cytotoxic (Huang‐Lee, Cheung, & Nimni, 1990;
McPherson, Sawamura, & Armstrong, 1986), but still used for reticula-
tion of biomedical products (Fürst & Banerjee, 2005). Silva et al.
showed that glutaraldehyde caused a much higher cytotoxicity than
ADH in fibroblast 3T3 cells, while dihydrazide‐induced cell death
occurred only at concentrations 300 times higher than those of glutar-
aldehyde (Silva et al., 2014), which supports its use as a preferable
crosslinker for biomedical applications. Our results strongly suggest
that the cytotoxic effect of the HGdil is most likely attributable to
the presence of ODEX free aldehydes. The formation of the HG
depends on the reaction of aldehydes present in ODEX with free
amines provided by ADH, producing hydrazone bonds, and the degra-
dation of HG is caused by the hydrolysis of those hydrazone bonds,
yielding again the original free ODEX and ADH components (Molinos
et al., 2012). Therefore, the biological reactivity of the HG is likely to
the presence of excess aldehyde groups, those not involved in
hydrazone bond formation. This phenomenon can also explain the
stronger cytotoxic effect of ODEX when used alone compared to
the HG, in TK6 cells exposed to higher concentrations of these agents
(C4, C5 and C6), i.e., ODEX by itself is more reactive than in the pres-
ence of ADH as all its aldehyde groups are free, while during forma-
tion of the HG some of the aldehydes react with ADH, thus
reducing the number of free aldehydes. The toxicity of other types
of aldehyde‐modified polysaccharides has been already reported for
other cell types, such as human and murine fibroblasts (Aziz et al.,
2015; Draye et al., 1998; Hyon, Nakajima, Sugai, & Matsumura,
2014; Rousseau & Gagnieu, 2002), macrophage cells (THP‐1 and
RAW 264.7) (Aziz et al., 2015; Sokolsky‐Papkov, Domb, & Golenser,
2006), epidermal keratinocytes, endothelial cells (Draye et al., 1998)
and nasopharyngeal epithelial cells (Aziz et al., 2015). For instance,
Aziz et al. (2015) assessed the cytotoxicity of the aldehyde‐modified
dextran (DA; 1.25‐30 mg/mL) using the xCELLigence system for
98 hours. DA showed a strong, dose‐dependent cytotoxic effect at
concentrations greater than 2.5 mg/mL in epithelial and macrophage
cells. Macrophage cells at the lowest DA concentration, however,
showed a mild inhibitory effect with a ~20% reduction in cell viability.
In fibroblasts, DA displayed a strong decrease of cell viability at condi-
tions greater than 5 mg/mL. After the combination between DA and
succinyl chitosan to obtain the dextran‐based hydrogel, this showed a
strong and immediate cytotoxic effect in epithelial cells, in contrast to
the macrophage and fibroblast cells, which exhibited a more moderate
response with a ~40% overall reduction in cell viability (Aziz et al.,
2015). The cytotoxic effect of aldehydes is most likely due to their reac-
tion with amino acids of the culture medium and free amines in the cell,
causing a negative effect on cellular growth (Hyon et al., 2014; Rous-
seau & Gagnieu, 2002). When the excess of aldehyde groups is reduced
to a primary alcohol (Rousseau & Gagnieu, 2002; Sokolsky‐Papkov
et al., 2006) or the degree of oxidation of the backbone is reduced
(Chan, Brooks, Moratti, Hanton, & Cabral, 2015), the biocompatibility
is highly improved. Although the aldehyde‐modified polysaccharide
derivatives showed some degree of cytotoxicity in vitro, several studies
have shown biocompatibility, safety and good performance in vivo in
diverse biomedical applications, such as hydrogels for the prevention
of postoperative adhesions (Athanasiadis et al., 2008; Ito et al., 2007;
Lauder, Strickland, & Maddern, 2012), surgical hemostatics (Rajivet al., 2013), bioadhesives and sealants (Artzi, Shazly, Baker, Bon, &
Edelman, 2009; Hoffmann et al., 2009). In fact, our group has already
shown that the HG presents excellent in vivo biocompatibility in a sub-
cutaneous implantation assay (Silva et al., 2016). This finding may be
explained by the slow degradation of the HG in vivo and by
dilution/excretion of the solubilized products, which most likely never
will reach the concentrations proved cytotoxic in the present work.
Despite extensive research on cytotoxicity (effects on cell
proliferation/viability) of aldehyde‐modified polysaccharides and
ADH, genotoxicity studies are still scarce, in particular, on ADH‐
reticulated polyaldehyde‐based hydrogels (Bouhadir, Hausman, &
Mooney, 1999; Hu et al., 2017; Maia et al., 2009; Schramm et al.,
2012; Su, Chen, & Lin, 2010). Genotoxicity is an important endpoint of
the safety assessment of regulated products, but no single test is
available to detect all types of genotoxicity. Therefore, a battery of
standard genotoxicity assays is recommended by ISO 10993‐3 (2014)
for the screening of potential genotoxicants. In this study, a detailed
genotoxicity assessment of a dextrin‐based hydrogel and its isolated
components to be used in medical devices for bone regeneration was
performed, using the CBMN, comet and the Ames assays. Among these
tests, CBMN and Ames are set out in ISO 10993‐3 guideline.
The CBMN assay is a sensitive method, which detects chromo-
somal damage in cells that have undergone cell division during or
following exposure to a test agent, through the observation of a
MN. The MN results from chromosomal loss or fragmentation, where
this damaged genetic material lags behind during chromosome segre-
gation and is not included in either of the resulting daughter nuclei
(Fenech, 2007). Our data showed that the HG, as well as its individual
components, did not induce an increase of MN frequency in binucle-
ate cells, suggesting that this dextrin‐based hydrogel does not pro-
mote chromosomal mutations.
The comet assay is a versatile, sensitive and rapidmethod formeasur-
ing DNA single‐ and double‐strand breaks at the level of individual cells
(Tice et al., 2000). It has been proposed as a valuable addition to the
MN assay due to its independence from cell proliferation and coverage
of a wider spectrum of DNA damage (Pfuhler et al., 2011) such as strand
breaks originated from direct interactions of a test agent with the DNA
molecule, alkali labile sites or transient DNA strand breaks resulting from
DNA excision repair mechanisms. This damage on DNA either can be
repaired, with no consequences for the cell, or may be fixed into a muta-
tion resulting in a permanent viable change or even may be lethal to the
cell. It may also lead to chromosomal damage, which is also associated
with many human diseases, including cancer (Fenech, 2007). In this test,
the length and fluorescence intensity of the comet tail is directly propor-
tional to the amount of DNA damage (Tice et al., 2000). In our study,
the basal DNA damage observed in TK6 cells were comparable to that
reported by others (Sharma et al., 2017; Sotiriou et al., 2014). The results
of the percentage tail intensity andOTM for cells exposed to HGdil, ODEX
and ADH were similar to the control, indicating that none of them
promotedDNAdamage at the concentrations tested. Genotoxic potential,
by using comet assay method, of self‐assembling dextrin nanogels
(Dextrin‐MVA‐SC16: MVA [vinyl methacrylate]; SC16 [alkyl chain]) has
been reported, showing an absence of DNA damage in 3T3 fibroblasts
and murine bone marrow‐derived macrophages in a range of concentra-
tions between 0.1 and 1 mg/mL of nanogel (Carvalho et al., 2011).
PEREIRA ET AL. 647The Ames test is the most classic test to evaluate the mutagenic
potential of chemicals. It is commonly employed as an initial screening
for genotoxic activity and, in particular, for point mutation‐inducing
activity. Point mutations are the cause of many human genetic
diseases and there is substantial evidence that point mutations in
oncogenes and tumor suppressor genes of somatic cells are involved
in tumor formation in humans (Tubbs & Nussenzweig, 2017). To test
the mutagenic toxicity of metabolized products, the S9 fraction, a rat
liver extract, was used in the assays.
Strains with different sensitivities to detect base substitutions and
frameshift mutations were used. In our study, the low number of pos-
itive wells and the lack of a dose‐response, either in the presence or
absence of S9 fractions suggest that the HG and its metabolites lack
mutagenic activity at the concentrations tested. Negative mutagenic-
ity results have been also reported for an HG composed by succinyl
chitosan and aldehyde dextran (0.5‐8 mg/mL) as assessed by the Ames
test (Aziz et al., 2015).
In conclusion, in this work, an oxidized dextrin‐based hydrogel
reticulated with ADH, previously developed by our group, aiming to
perform as an injectable carrier of hydroxyapatite granules for bone tis-
sue engineering and as a drug delivery system was characterized for
cyto‐ and genotoxicity. Genotoxicity is an important endpoint in the
safety assessment of medical devices but is often undervalued by poly-
meric biomaterial researchers in the biomedical field. The obtained
results demonstrated that HG is non‐genotoxic and non‐mutagenic
under the experimental conditions tested, confirming the huge poten-
tial of this HG for biomedical applications. In vivo studies are being per-
formed to confirm the safety of HG for such applicability. To the best
of our acknowledge, this is the first report with a detailed genotoxicity
assessment of an aldehyde‐modified polysaccharide/ADH hydrogel.ACKNOWLEDGEMENTS
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